Kejiang Xiao - Search Results

Year	Number of Results
1990	2
1991	1
1999	1
2000	2
2001	2
2002	2
2003	8
2004	14
2005	23
2006	22
2007	31
2008	32
2009	53
2010	46
2011	63
2012	108
2013	149
2014	247
2015	296
2016	346
2017	446
2018	457
2019	527
2020	698
2021	873
2022	1024
2023	1150
2024	498

1

Mannose metabolism normalizes gut homeostasis by blocking the TNF-α-mediated proinflammatory circuit.

Xiao P, Hu Z, Lang J, Pan T, Mertens RT, Zhang H, Guo K, Shen M, Cheng H, Zhang X, Cao Q, Ke Y. Xiao P, et al. Cell Mol Immunol. 2023 Feb;20(2):119-130. doi: 10.1038/s41423-022-00955-1. Epub 2022 Dec 5. Cell Mol Immunol. 2023. PMID: 36471112 Free PMC article.

2

Butyrate reverses ferroptosis resistance in colorectal cancer by inducing c-Fos-dependent xCT suppression.

He Y, Ling Y, Zhang Z, Mertens RT, Cao Q, Xu X, Guo K, Shi Q, Zhang X, Huo L, Wang K, Guo H, Shen W, Shen M, Feng W, Xiao P. He Y, et al. Redox Biol. 2023 Sep;65:102822. doi: 10.1016/j.redox.2023.102822. Epub 2023 Jul 20. Redox Biol. 2023. PMID: 37494767 Free PMC article.

3

Immunotherapies for advanced hepatocellular carcinoma.

Sun LY, Zhang KJ, Xie YM, Liu JW, Xiao ZQ. Sun LY, et al. Front Pharmacol. 2023 Mar 21;14:1138493. doi: 10.3389/fphar.2023.1138493. eCollection 2023. Front Pharmacol. 2023. PMID: 37025485 Free PMC article. Review.

4

Nickelacarborane-Supported Bis-N-heterocyclic Carbenes.

Nan R, Li Y, Zhu Z, Qi F, Xiao XQ. Nan R, et al. J Am Chem Soc. 2023 Jul 19;145(28):15538-15546. doi: 10.1021/jacs.3c04360. Epub 2023 Jul 6. J Am Chem Soc. 2023. PMID: 37413790

5

Pyroptosis in diabetic nephropathy.

Al Mamun A, Ara Mimi A, Wu Y, Zaeem M, Abdul Aziz M, Aktar Suchi S, Alyafeai E, Munir F, Xiao J. Al Mamun A, et al. Clin Chim Acta. 2021 Dec;523:131-143. doi: 10.1016/j.cca.2021.09.003. Epub 2021 Sep 13. Clin Chim Acta. 2021. PMID: 34529985 Review.

6

Reprogramming natural killer cells for cancer therapy.

Wang K, Wang L, Wang Y, Xiao L, Wei J, Hu Y, Wang D, Huang H. Wang K, et al. Mol Ther. 2024 Jan 24:S1525-0016(24)00027-3. doi: 10.1016/j.ymthe.2024.01.027. Online ahead of print. Mol Ther. 2024. PMID: 38273655 Review.

7

Rigosertib promotes anti-tumor immunity via autophagic degradation of PD-L1 in colorectal cancer cells.

Zhou X, Fu D, Yang H, Le C, Lu Y, Wei J, Tang Y, Zhang J, Yuan Y, Ding K, Xiao Q. Zhou X, et al. Cancer Lett. 2023 Nov 28;577:216422. doi: 10.1016/j.canlet.2023.216422. Epub 2023 Oct 5. Cancer Lett. 2023. PMID: 37805162 Free article.

8

Metal@Zeolite Hybrid Materials for Catalysis.

Wang H, Wang L, Xiao FS. Wang H, et al. ACS Cent Sci. 2020 Oct 28;6(10):1685-1697. doi: 10.1021/acscentsci.0c01130. Epub 2020 Sep 25. ACS Cent Sci. 2020. PMID: 33145408 Free PMC article. Review.

9

Editorial: Oral Nanotherapeutics for Colon Diseases.

Duan L, Zheng F, Merlin D, Wang H, Xiao Z, Xiao B. Duan L, et al. Front Bioeng Biotechnol. 2021 Dec 9;9:816304. doi: 10.3389/fbioe.2021.816304. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34957086 Free PMC article. No abstract available.

10

Targeting RAS mutants in malignancies: successes, failures, and reasons for hope.

Yang H, Zhou X, Fu D, Le C, Wang J, Zhou Q, Liu X, Yuan Y, Ding K, Xiao Q. Yang H, et al. Cancer Commun (Lond). 2023 Jan;43(1):42-74. doi: 10.1002/cac2.12377. Epub 2022 Oct 31. Cancer Commun (Lond). 2023. PMID: 36316602 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

6,339 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

6,339 results

Results by year